Salesforce, Inc. (CRM) is a customer relationship management (CRM) and enterprise cloud-software company, not an exchange-traded fund. Across the roughly 56 analyst price targets compiled in late October 2026, the arithmetic mean sits near $287, which rounds to a central stock price target of $290. The analyst price target range is unusually wide — from a cautious low near $195 to a Street-high of $400 — signaling that Wall Street is far from unanimous.
Named examples illustrate the split. Mizuho Securities analyst Gregg Moskowitz reiterated a Buy rating with a $350 target in early October 2026, while Cantor Fitzgerald maintained an Overweight rating and a $300 target. On the cautious side, a handful of firms carry targets well below the current price, arguing that Salesforce's growth is still decelerating despite headline beats. The bulk of coverage remains constructive, with a clear majority of ratings in the Buy or Strong Buy camp.
Because this figure is the average of many individual analyst targets rather than an independently published consensus, it should be read as a rough center of opinion — not a guarantee or a forecast.
As of its most recent close near $229.17, reaching $290 would require upside of about 26%, which is a substantial move rather than a modest drift. The path would first require clearing the stock's 52-week high around $269, a level that has repeatedly acted as resistance, before extending toward $290.
Fundamentally, the company has posted solid results: quarterly revenue grew roughly 11% year over year, while net margin improved to around 31%, and the company announced a $5.66 billion acquisition of real-time marketing platform Braze to deepen its Marketing Cloud. Whether the stock can translate this into a sustained re-rating depends on re-accelerating organic growth and convincing evidence that the AI product cycle is expanding the revenue base rather than merely defending it.
The most important support is Agentforce, Salesforce's autonomous AI-agent platform, which has become the centerpiece of the bull case as enterprise adoption and usage metrics climb. Combined with the company's expanding margins, strong free cash flow, and ongoing share repurchases, this positions Salesforce as a beneficiary of the agentic-AI buildout in the enterprise.
The Braze acquisition, while costly, could broaden the marketing offering and accelerate cross-selling. Recent analyst activity has skewed positive, including upgrades and maintained Buy ratings that frame Salesforce as attractively valued after its pullback. A forward price-to-earnings (P/E) ratio in the mid-teens also leaves room for multiple expansion if growth re-accelerates.
The principal risk is that organic revenue growth continues to decelerate, and that AI-native competitors — including major AI labs and hyperscalers moving into enterprise applications — erode Salesforce's pricing power and seat-based economics. The Braze deal also introduces near-term integration costs and margin pressure, which some analysts cite as a drag on fiscal-year profitability.
Valuation compression is another hurdle: if investors conclude that AI agents reduce, rather than expand, software spending, the stock's multiple could contract even on stable earnings. The wide $195-to-$400 target range underscores that a meaningful minority of analysts expect the shares to move lower, not higher.
Technically, the shares sit below their 50-day moving average near $239 but above the 200-day moving average near $198, leaving the intermediate trend unsettled. The 52-week high near $269 is the most significant resistance level a move toward $290 would need to overcome. On the downside, support is visible near $220, with the $200 area and the 200-day average providing deeper cushions. A decisive break above $269 would be the clearest structural signal that a run toward $290 is underway.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary. Investors should monitor the next quarterly earnings report, guidance for organic (constant-currency) revenue growth, and margin commentary tied to the Braze integration. Also watch Agentforce adoption metrics, any analyst target revisions, and broader software-sector sentiment around AI monetization. A sustained move above the $269 prior high — or a breakdown below $200 — would meaningfully reshape the outlook.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use the tool to surface new opportunities, keep an eye on existing positions, and spot shifting trends more efficiently than manual screening allows. For those who follow names like Salesforce, the signals offer a systematic complement to fundamental research.
The question of whether Salesforce can reach $290 hinges on a real, verifiable gap: roughly 26% above its latest close. The central target reflects an average of analyst views that span a very wide range, from cautious targets near $195 to bullish targets of $400, which itself signals that the outcome is far from settled. Strong margins, the Agentforce narrative, and the Braze deal support the upside case, while decelerating growth, AI-driven competition, and integration risk are the principal obstacles. Investors should watch earnings guidance, Agentforce momentum, and the $269 resistance level. No analyst target — and no average of them — is a guarantee of where the shares will trade.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CRM has been closely correlated with ADBE. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRM jumps, then ADBE could also see price increases.
| Ticker / NAME | Correlation To CRM | 1D Price Change % | ||
|---|---|---|---|---|
| CRM | 100% | -3.72% | ||
| ADBE - CRM | 76% Closely correlated | -2.00% | ||
| HUBS - CRM | 76% Closely correlated | -6.40% | ||
| WDAY - CRM | 75% Closely correlated | -2.30% | ||
| NOW - CRM | 73% Closely correlated | -1.90% | ||
| FRSH - CRM | 71% Closely correlated | -3.91% | ||
More | ||||
| Ticker / NAME | Correlation To CRM | 1D Price Change % |
|---|---|---|
| CRM | 100% | -3.72% |
| CRM (14 stocks) | 76% Closely correlated | -0.71% |
| Packaged Software (219 stocks) | 17% Poorly correlated | +0.43% |
| Technology Services (392 stocks) | 14% Poorly correlated | -1.55% |